{"date":"2026-09-16","count":21,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2026-09-16-2156-1n5osjp","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"21:56:40","subject":"代重要子公司Alvogen Korea Co., Ltd.公告董事當選名單","clause":"第6款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-16 21:56，「代重要子公司Alvogen Korea Co., Ltd.公告董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-09-16-2156-1viq9j0","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"21:56:27","subject":"公告本公司因新加坡子公司減資退還股款取得應收債權案","clause":"第20款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-16 21:56，「公告本公司因新加坡子公司減資退還股款取得應收債權案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-09-16-2156-n0zddv","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"21:56:11","subject":"代重要子公司Lotus International Pte. Ltd.公告減資事宜","clause":"第11款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-16 21:56，「代重要子公司Lotus International Pte. Ltd.公告減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-09-16-2155-hyb89","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"21:55:48","subject":"代重要子公司Lotus International Pte. Ltd.公告2026年股東臨時會重要決議事項","clause":"第18款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-16 21:55，「代重要子公司Lotus International Pte. Ltd.公告2026年股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-09-16-2155-ysgi7o","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"21:55:36","subject":"代重要子公司Lotus International Pte. Ltd.公告召開2026年股東臨時會","clause":"第17款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-16 21:55，「代重要子公司Lotus International Pte. Ltd.公告召開2026年股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-09-16-2152-img73l","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"21:52:18","subject":"代重要子公司Alvogen Korea Co., Ltd.公告2026年股東臨時會重要決議事項","clause":"第18款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-09-16 21:52，「代重要子公司Alvogen Korea Co., Ltd.公告2026年股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-09-16-1930-dosw16","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"19:30:42","subject":"公告本公司辦理限制員工權利新股註銷減資變更登記完成","clause":"第36款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-09-16 19:30，「公告本公司辦理限制員工權利新股註銷減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2026-09-16-1800-16sohr8","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2026-09-16","time":"18:00:13","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：進階（3118），2026-09-16 18:00，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-09-16-1725-1czi1ae","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"17:25:00","subject":"公告本公司115年09月22日受邀參加台新綜合證券舉辦之法人說明會，說明公司營運概況及未來展望。","clause":"第12款","fact_date":"2026-09-22","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-09-16 17:25，「公告本公司115年09月22日受邀參加台新綜合證券舉辦之法人說明會，說明公司營運概況及未來展望。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-09-16-1627-86p3cw","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"16:27:33","subject":"公告董事會決議通過子公司普陽開發科技(股)公司取得不動產","clause":"第20款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-09-16 16:27，「公告董事會決議通過子公司普陽開發科技(股)公司取得不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-09-16-1626-1sq0wcf","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"16:26:11","subject":"公告董事會決議通過子公司普陽開發科技(股)公司取得土地、廠房","clause":"第20款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-09-16 16:26，「公告董事會決議通過子公司普陽開發科技(股)公司取得土地、廠房」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2026-09-16-1614-1ygijv0","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-09-16","time":"16:14:06","subject":"代孫公司艾司博迪亞(上海)生物科技有限公司公告研發中之ADC新藥ACE723第一期臨床試驗獲中國NMPA核准執行","clause":"第8款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-09-16 16:14，「代孫公司艾司博迪亞(上海)生物科技有限公司公告研發中之ADC新藥ACE723第一期臨床試驗獲中國NMPA核准執行」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-09-16-1603-1wmr41q","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-09-16","time":"16:03:00","subject":"公告本公司訂定現金增資發行新股認股基準日等相關事宜(補充代收款項及存儲款項機構等相關事宜）","clause":"第9款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-09-16 16:03，「公告本公司訂定現金增資發行新股認股基準日等相關事宜(補充代收款項及存儲款項機構等相關事宜）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-09-16-1518-w4zfku","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-09-16","time":"15:18:02","subject":"公告本公司董事會推選副董事長。","clause":"第6款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-09-16 15:18，「公告本公司董事會推選副董事長。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-09-16-1517-1m1xl7o","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-09-16","time":"15:17:32","subject":"公告本公司115年第1次股東臨時會解除新任董事之競業禁止限制案。","clause":"第22款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-09-16 15:17，「公告本公司115年第1次股東臨時會解除新任董事之競業禁止限制案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-09-16-1516-i61ef5","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-09-16","time":"15:16:50","subject":"公告本公司115年第1次股東臨時會補選1席董事。","clause":"第6款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-09-16 15:16，「公告本公司115年第1次股東臨時會補選1席董事。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-09-16-1515-6tpzk5","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-09-16","time":"15:15:59","subject":"公告本公司115年第1次股東臨時會重要決議事項。","clause":"第15款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-09-16 15:15，「公告本公司115年第1次股東臨時會重要決議事項。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-09-16-1433-ag0ktz","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"14:33:07","subject":"本公司受邀參加永豐金證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-09-16 14:33，「本公司受邀參加永豐金證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2026-09-16-1421-111oxrq","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2026-09-16","time":"14:21:00","subject":"補充公告本公司董事會決議召開115年第二次股東臨時會相關事宜(增列議案)","clause":"第17款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2026-09-16 14:21，「補充公告本公司董事會決議召開115年第二次股東臨時會相關事宜(增列議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-09-16-1418-1g9s9ga","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-09-16","time":"14:18:27","subject":"代子公司合富生化科技股份有限公司公告董事會決議減資案","clause":"第11款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-09-16 14:18，「代子公司合富生化科技股份有限公司公告董事會決議減資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-09-16-1417-1sm5xbj","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-09-16","time":"14:17:42","subject":"公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜","clause":"第23款","fact_date":"2026-09-16","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-09-16 14:17，「公告本公司集團間資金貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第1款相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}